IDEAYA Biosciences, Inc.
IDYA
$33.09
$0.260.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -94.77% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -94.77% | -- | |||
| Cost of Revenue | 4.34% | 11.81% | |||
| Gross Profit | -160.66% | 268.19% | |||
| SG&A Expenses | 15.00% | 12.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.10% | 11.91% | |||
| Operating Income | -187.20% | 222.12% | |||
| Income Before Tax | -169.83% | 253.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -169.83% | 253.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -169.83% | 253.88% | |||
| EBIT | -187.20% | 222.12% | |||
| EBITDA | -186.01% | 223.87% | |||
| EPS Basic | -169.79% | 253.78% | |||
| Normalized Basic EPS | -178.14% | 253.80% | |||
| EPS Diluted | -170.98% | 251.84% | |||
| Normalized Diluted EPS | -179.18% | 251.79% | |||
| Average Basic Shares Outstanding | 0.06% | 0.06% | |||
| Average Diluted Shares Outstanding | -1.24% | 1.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||